Robert-Richard, Elodie <br/><br/>
Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.  [electronic resource] 

 -  American journal of human genetics  Jan 2008 
 - 113-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6605 
<br/><br/><label>Standard No.: </label>10.1016/j.ajhg.2007.09.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Survival<br/>Disease Models, Animal<br/>Erythrocytes<br/>Female<br/>Genetic Therapy<br/>Genetic Vectors<br/>Hematopoietic Stem Cells<br/>Lentivirus<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Porphyria, Erythropoietic--genetics<br/>Uroporphyrinogen III Synthetase--genetics